Clostridium difficile-associated disease: Implications for midwifery practice

Journal of Nurse-Midwifery

Volumn 44, Issue 1, 1999, Pages 19-29

  Alef, Katrina ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE;

ADULT; CASE REPORT; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LACTATION; NURSE MIDWIFE; NURSING; PREGNANCY; PREGNANCY COMPLICATION; PSEUDOMEMBRANOUS COLITIS; REVIEW;

ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LACTATION; METRONIDAZOLE; NURSE MIDWIVES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0032609198     PISSN: 00912182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-2182(98)00074-3     Document Type: Article

References (132)

1. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993;269:71-5.
2. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
3. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associaied diarrhea and colitis. Am J Gastroenterol 1997;92:739-50.
4. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
5. Bowen KE, McFarland LV, Greenberg RN, Ramsey MM, Record KE, Svenson J. Isolation of Clostridium difficile at a university hospital: a two-year study. Clin Infect Dis 1995;20 Suppl 2:261-2.
6. Karlstrom O, Fryklund B, Tallus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis 1998;26:141-5.
7. Frost F, Craun GF, Calderon RL. Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease. Emerg Infect Dis [serial online] 1998;4(4). Available at: http://www. cdc.gov/ncidod/EID/vol4no4/frost.htm. Accessed November 5, 1998.
8. Counihan TC, Roberts PL. Pseudomembranous colitis. Surg Clin North Am 1993;73:1063-74.
9. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-77.
10. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995;169:480-3.
11. Ho M, Yang D, Wyle FA, Mulligan ME. Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use. Clin Infect Dis 1996;23 Suppl 1:102-6.
12. Aronsson B, Mollby R, Nord C-E. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985;151:476-81.
13. Brown E, Talbot GM, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990; 11:283-90.
14. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45:1-24.
15. Clay LS. Group B streptococcus in the perinatal period: a review. J Nurse Midwifery 1996;41:355-63.
16. American College of Nurse-Midwives. Early onset group B strep infection in newborns: prevention and prophylaxis. J Nurse Midwifery 1997;42:403-8.
17. Knoop FC, Owens M, Crocker C. Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev 1993;6:251-65.
18. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective, casecontrolled epidemiologic study. Arch Intern Med 1986;146:95-100.
19. Bartlett, JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990;12 Suppl 2:243-51.
20. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15:573-81.
21. Hooker KD, DiPiro JT. Effect of antimicrobial therapy on bowel flora. Clin Pharm 1988;7:878-88.
22. Borriello SP. The influence of the normal flora on Clostridium difficile colonization of the gut. Ann Med 1990;22:61-7.
23. Hentges DJ. The anaerobic microflora of the human body. Clin Infect Dis 1993; 16 Suppl 4:175-80.
24. Pothoulakis C, LaMont JT. Clostridium difficile colitis and diarrhea. Gastroenterol Clin North Am 1993;22:623-37.
25. Wilson KH. The microecology of Clostridium difficile. Clin Infect Dis 1993; 16 Suppl 4:214-8.
26. Larson HE, Barclay PE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727-33.
27. Borriello SP. Pathogenesis of Clostridium difficile infection of the gut. J Med Microbiol 1990;33:207-15.
28. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
29. Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonization and disease. Lancet 1990;336:97-100.
30. Hirschorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994;169:127-33.
31. Olson MM, Shanholzer MT, Lee JT Jr, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371-81.
32. Struelens MJ, Maas A, Nonhoff C, et al. Control of nosoco-mial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991-91 Suppl 3B:138-44.
33. Andrejak M, Schmit JL, Tondriaux A. The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s. Drug Saf 1991;6:339-49.
34. James AH, Katz VL, Dotters DJ, Rogers RG. Clostridium difficile infection in obstetric and gynecology patients. South Med J 1997;90:889-92.
35. Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admission as a source of infection. J Infect Dis 1992;166:561-7.
36. Fekety R, Kim KH, Brown D, Batts DH, Cudmore M, Silva J Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med 1981;70: 906-8.
37. Nolan NPM, Kelly CP, Humphries JF, et al. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut 1987;28:1467-73.
38. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88:137-40.
39. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibioticassociated colitis. J Infect Dis 1981;143:42-50.
40. Malamou-Ladas H, O'Farrell SO, Nash JO, Tabaqchali S. Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol 1983;36:88-92.
41. Savage AM, Alford RH. Nosocomial spread of Clostridium difficile. Infect Control 1983;4:31-3.
42. Brooks SE, Veal RO, Kramer M, Dore L, Schupf N, Adachi M. Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992;13:98-103.
43. Manian FA, Meyer L, Jenne J. Clostridium difficile contamination of blood pressure cuffs: a call for a closer look at gloving practices in the era of universal precautions. Infect Control Hosp Epidemiol 1996;17:180-2.
44. Boardman A. Diagnosis and management of pseudomembranous colitis and Clostridium difficile-associated disease. Prim Care Update Ob/Gyns 1998;5:219-28.
45. Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994;18 Suppl 4:265-72.
46. DeMaio J, Bartlett JG. Update on diagnosis of Clostridium difficile-associated diarrhea. Curr Clin Top Infect Dis 1995;15:97-114.
47. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998-26:102-34.
48. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary asymptomatic colonization by Clostridium difficile is associated with a decreased risk of subsequent C difficile diarrhea. Lancet 1998;351:633-6.
49. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 1991;12:345-8.
50. Block BS, Mercer LJ, Ismail MA, Moawad AH. Clostridium difficile-associated diarrhea follows perioperative prophylaxis with cefoxitin. Am J Obstet Gynecol 1985;153:835-8.
51. Privitera G, Scarpellini P, Ortisi G, Nicastro G, Nicolin R, de Lalla F. Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother 1991;35:208-10.
52. Yee J, Dixon CM, McLean PH, Meakins JL. Clostridium difficile disease in a department of surgery. Arch Surg 1991;126: 241-6.
53. Bartlett JG. Antimicrobial agents implicated in Clostridium difficile toxin associated diarrhea or colitis. Johns Hopkins Med J 1981;149:6-9.
54. Bartlett JG. The ten most common questions about Clostridium difficile-associated diarrhea/colitis. Infect Dis Clin Prac 1992-1: 254-9.
55. Anand A, Bashey B, Mir T, Glatt AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994;89:519-23.
56. Marts BC, Longo WE, Vernava AM III, Kennedy DJ, Daniel GL, Jones I. Patterns and prognosis of Clostridium difficile colitis. Dis Colon Rectum 1994;37:837-45.
57. Nelson DE, Auerbach SB, Baltch AL, et al. Epidemic Clostridium difficile-associated diarrhea: role of second and third generation cephalosporins. Infect Control Hosp Epidemiol 1994;15:88-94.
58. Gerding DN, Olson MM, Johnson S, Peterson LR, Lee JT Jr. Clostridium difficile diarrhea and colonization after treatment with abdominal infection regimens containing clindamycin or metronidazole. Am J Surg 1990;159:212-7.
59. Reinke CM, Messick CR. Update on Clostridium difficile-induced colitis, part 1. Am J Hosp Pharm 1994;51:1771-81.
60. Cudmore MA, Silva J Jr, Fekety R, Liepman MK, Kim KH. Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med 1982; 142:333-5.
61. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993; 17: 109-13.
62. Job ML, Jacob NF. Drug-induced Clostridium difficile-associated disease. Drug Saf 1197;17:17-46.
63. Cozart JC, Kalangi SS, Clench MH, et al. Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment. J Clin Gastroenterol 1993;16:192-4.
64. Melillo KD. Clostridium difficile and older adults: what primary care providers should know. Nurse Prac 1998;23:25-43.
65. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997;24: 324-33.
66. Tedesco FJ. Pseudomembranous colitis: pathogenesis and therapy. Med Clin North Am 1986;66:655-64.
67. Godet AS, Williams RD. Postoperative Clostridium difficile gastroenteritis. J Urol 1993;149:142-4.
68. Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized placebo-controlled trial. Ann Intern Med 1992;117:279-302.
69. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infection. Clin Infect Dis 1993; 16 Suppl 4:43942.
70. Gerding DN. Diagnosis of Clostridium difficile-associated disease: patient selection and test perfection. Am J Med 1996;100: 485-6.
71. Doern GV, Coughlin RT, Wu L. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytoxicity assays. J Clin Microbiol 1992;30: 2042-6.
72. Jacobs J, Rudensky B, Dresner J, et al. Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis 1996;15:561-6.
73. Merz CS, Kramer C, Forman M, et al. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol 1994;32:1142-7.
74. Reinke CM, Messick CR. Update on Clostridium difficileinduced colitis, part 2. Am J Hosp Pharm 1994;51:1892-901.
75. Church JM, Fazio WW. A role for colonic stasis in the pathogenesis related to Clostridium difficile. Dis Colon Rectum 1986;29: 804-9.
76. Bolton RP, Culshaw MA. Fecal metronidazole concentrations during oral and intravenous therapy for antibiotic-associated colitis due to Clostridium difficile. Gut 1986;27:1169-72.
77. Burdon DW, Brown JD, Youngs DJ, et al. Antibiotic susceptibiltity of Clostridium difficile. J Antimicrob Chemother 1979;5: 307-10.
78. Dzink J, Bartlett JG. In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother 1980;17:695-8.
79. Teasley DG, Gerding DN, Olson MM, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 1983;2:1043-6.
80. Wilcox MH, Howe R. Diarrhea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicrob Chemother 1995;36:673-9.
81. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995;23: 87-94.
82. Lam S, Singer C, Tucci V, Morthland VH, Pfaller MA, Isenberg HD. The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study. Am J Infect Control 1995;23:170-80.
83. Quale J, Landman O, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23:1020-5.
84. Bartlett, JG. Metronidazole. Johns Hopkins Med J 1981;149: 89-92.
85. Fekety R, Silva J, Kauffman C, Buggy B, Deery HG. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989; 86:15-9.
86. Dudley MN, McLaughlin JC, Carrington G, Frick J, Nightingale CH, Quintiliani R. Oral bacitracin versus vancomycin therapy for Clostridium difficile-induced diarrhea: a randomized double-blind trial. Arch Intern Med 1986;146:1101-4.
87. de Lalla F, Nicolin R, Rinaldi E, et al. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother 1992;36:2192-6.
88. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis;22:813-8.
89. Kelly CP, LaMont JT. Clostridium difficile infection. Ann Rev Med 1998;49:375-90.
90. Morris JB, Zollinger RM, Stellato TA. Role of surgery in antibiotic-induced pseudomembranous colitis. Am J Surg 1990;160: 535-9.
91. Johnson S, Adelman A, Clabots CR, Peterson LR, Gerding DN. Recurrences of Clostridium difficile not caused by the original infecting organism. J Infect Dis 1989;159:340-3.
92. Wilcox MH, Spencer RC. Clostridium difficile infection: responses, relapses, and reinfections. J Hosp Infect 1992;22:85-92.
93. Wilcox MH, Fawley WN, Settle CD, Davidson A. Recurrence of symptoms in Clostridium difficile infection: relapse or reinfection? J Hosp Infect 1998;38:93-100.
94. Tedesco FJ. Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1982;77:220-1.
95. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985;80:867-8.
96. Pruksananonda P, Powell KR. Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine. Pediatr Infect Dis J 1989;8:175-8.
97. Moncino MD, Falletta JM. Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient: successful control with long-term cholestyramine therapy. Am J Pediatr Hematol Oncol 1992;14:361-4.
98. Seal D, Borriello SP, Barclay F, Welch A, Piper M, Bonnycastle M. Treatment of relapsing Clostridium difficile diarrhea by administration of a non-toxigenic strain. Eur J Clin Microbiol 1987;6: 51-3.
99. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhea in six patients. Lancet 1989;1: 1156-60.
100. Gorbach SL, Chang T, Golden B. Successful treatment of relapsing C difficile colitis with Lactobacillus GG [letter]. Lancet 1987;2:1519.
101. Surawicz CM, McFarland LV, Elmer G, Chinn J. Treatment of recurrent C difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989;84:1285-7.
102. Kimmey MB, Elmer GW, Surawicz CM, McFarland LV. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Sei 1990;35:837-901.
103. Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterol 1993;104:1108-15.
104. McFarland LV, Surawicz CM, Greenberg RN, et al. Randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Womens Assoc 1994;271:1913-8.
105. Beard CM, Noller KL, O'Fallon WM, Kurland LT, Dahlin DC. Cancer after exposure to metronidazole. Mayo Clin Proc 1988;63: 147-53.
106. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins, 1994.
107. Freeman CD, Klutman NE, Camp KC. Metronidazole: a therapeutic review and update. Drugs 1997;54:679-708.
108. Friedman JM, Polifka JE. The effects of drugs on the fetus and nursing infant. Baltimore (MD): Johns Hopkins University Press, 1996.
109. Peterson JF. Metronidazole in pregnancy. Am J Obstet Gynecol 1966;94:343-9.
110. Cantu JM, Garcia-Cruz D. Midline facial defect as a teratogenic effect of metronidazole. Birth Defects 1982;18:85-8.
111. Greenberg F. Possible metronidazole teratogenicity and clefting [letter]. Am J Med Genet 1985;22:825.
112. Czeizel AE, Rockenbauer M. A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998;105:322-7.
113. Morgan L. Metronidazole treatment in pregnancy. Int J Gynecol Obstet 1978;15:501-2.
114. Aselton P, Jick H, Milunsky A, Hunter JR, Stergasis A. First trimester drug use and congenital disorders. Obstet Gynecol 1985;65: 451-5.
115. Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first trimester vaginitis drug therapy. Obstet Gynecol 1987;69:751-5.
116. Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth difects: no association. Obstet Gynecol 1993;82:348-52.
117. Burtin P, Taddio A, Ariburnu D, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:575-9.
118. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled double-blind study. Am J Obstet Gynecol 1994;171:345-9.
119. Heisterberg L, Branebjerg PE. Blood and milk concentrations of metronidazole in mothers and infants. J Perinat Med 1983;11: 114-20.
120. Passmore CM, McElnay JC, Rainey EA, D'Arcy PF. Metronidazole excretion in human milk and its effects on the suckling neonate. Br J Clin Pharmacol 1988;26:45-51.
121. Rom S, Flynn D, Noone P. Anaerobic infection in a neonate. Early detection by gas liquid chromatography and response to metronidazole. Arch Dis Child 1977;52:740-1.
122. Jager-Roman E, Doyle PE, Baird-Lambert J, Cvejic M, Buchanan N. Pharmacokinetics and tissue distribution of metronidazole in the newborn infant. J Pediatr 1982;100:651-4.
123. Danesh IS, Stephen JM, Gorbach J. Neonatal trichomonas vaginalis infection. J Emerg Med 1995;13:51-4.
124. Aucher P, Saunier JP, Grollier G, Sebald M, Fauchere JL. Meningitis due to enterotoxigenic Bacteroides fragilis. Eur J Clin Microbiol Infect Dis 1996;15:820-3.
125. The WHO Working Group, Bennet PN, editor. Drugs and human lactation. New York: Elsevier, 1988.
126. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-150.
127. Erickson SH, Oppenheim GL, Smith GH. Metronidazole in breastmilk. Obstet Gynecol 1981;57:48-50.
128. American Academy of Pediatrics Working Group on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 1997; 100:1035-9.
129. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127:1289-94.
130. Bender BS, Bennett R, Laughon BE, et al. Is Clostridium difficile endemic in chronic care facilities? Lancet 1986;2:11-3.
131. Kerr RB, McLaughlin DI, Sonnenberg LW. Control of Clostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole. Am J Infect Control; 18:332-3.
132. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120:272-7.